Our Strategy Advisory Group

NCRI’s Strategy Advisory Group provides strategic advice to the NCRI Partnership, via the NCRI Executive and the Board of Trustees, regarding the implementation of the current NCRI strategy and the development of future strategies. The Strategy Advisory Group consists of thought leaders drawn from across the research spectrum from basic science through translational and clinical research to living with and beyond cancer research.


Tim MaughanProfessor Tim Maughan

Tim Maughan was appointed Professor of Clinical Oncology and Clinical Director of the CRUK/MRC Oxford Institute for Radiation Oncology in the Department of Oncology in 2011.  Previously, Tim worked as an NHS consultant Clinical Oncologist in Cardiff, becoming Professor of Cancer Studies in 2007.  During that time, he established the first clinical research network, the Wales Cancer Trials Network, and subsequently the development of the clinical research networks across the UK.  He was the founding chair of the NCRI Clinical and Translational Radiotherapy Research Working Group (CTRad), which has a broad remit to enhance radiotherapy research in the UK.


Deputy Chair

Professor Paul Workman

Paul Workman is Chief Executive and President of The Institute of Cancer Research (ICR). In 1997, Paul moved to the Institute of Cancer Research (ICR) to take over and build up what is now the CRUK Cancer Therapeutics Unit, and held the position of unit Director until January 2016 – a period of over 18 years. Under his leadership, the Unit has identified 20 clinical drug candidates since 2005, has progressed 10 of its drugs into Phase I clinical trials in ICR’s partner Royal Marsden Hospital, and has seen its prostate cancer drug approved by the US FDA, European Medicines Agency and NICE and successfully launched.



Professor Manuel Salto-Tellez: Chair of Molecular Pathology at Queen’s University Belfast, Clinical Consultant Pathologist at the Belfast Health and Social Care Trust and Deputy Director of the Centre for Cancer Research and Cell Biology.

Professor Richard Gilbertson: Director of the CRUK Cambridge Centre at Cambridge University.

Professor Sarah Blagden: Associate Professor of Experimental Cancer Therapeutics in the Department of Oncology at Oxford

Professor Ruth Plummer: Professor of Experimental Cancer Medicine at the Northern Institute for Cancer Research, Director of the Sir Bobby Robson Cancer Trials Research Centre, lead of the Newcastle Experimental Cancer Medicine Centre and the CRUK Newcastle Cancer Centre.

Professor Andrew Tutt: Head of the Division of Breast Cancer Research and Director of the Breast Cancer Now Toby Robins Research Centre at the ICR and Guy’s Hospital King’s College London.

Dr Anthony Byrne: Clinical director of the Marie Curie Palliative Care Research Centre.

Dr Erik Sahai: Group Leader of the Tumour Cell Biology lab at the Francis Crick Institute.

Emma Kinloch: Chair of the NCRI Consumer Forum and member of the NCRI Head and Neck Group, founder of the London based Head and Neck cancer support group, member of the Head and Neck EURACAN domain and on the Board of Directors for Salivary Gland Cancer UK.

Dr Rob Jones: Reader and Consultant in Medical Oncology Cardiff, Specialty Lead for Cancer in Wales, and Lead for Cancer Phase 1 trials in Wales.

Professor Matt Seymour: Chair of Gastrointestinal Cancer Medicine at the University of Leeds, Director of the NIHR Cancer Research Network and Clinical Research Director of the NCRI.

Professor David Cameron: Professor of Oncology at Edinburgh University, Director of Cancer Services in NHS Lothian and Chief Scientist’s Office Clinical Cancer Research Champion.

Dr Helen Campbell: Portfolio Manager for Department of Health Research Networks, Cancer Research, and Clinical Research Facilities.

Dr Stuart McIntosh: Consultant Breast Surgeon at Belfast City Hospital and Deputy Lead for the Northern Ireland Cancer Trials Network.

Dr Ian Walker: Director of Clinical, Population and Early Detection Research at CRUK.

Dr Sabine Best: Head of Research at Marie Curie.

Dr Alasdair Rankin: Director of Research at the blood cancer charity Bloodwise.

Dr Jonathan Pearce: Associate Director, Biological Medicine, Medical Research Council.

Professor Michael Baumann: Chairman and Scientific Director of the German Cancer Research Centre (Deutsches Krebsforschungszentrum, DKFZ).

Sean Buckland: Senior Medical Affairs Advisor at Pfizer Oncology UK and ABPI Cancer Project Group representative for the NCRI Strategy Advisory Group.